Search

Your search keyword '"Melki, Isabelle"' showing total 302 results

Search Constraints

Start Over You searched for: Author "Melki, Isabelle" Remove constraint Author: "Melki, Isabelle"
302 results on '"Melki, Isabelle"'

Search Results

2. French protocol for the diagnosis and management of systemic lupus erythematosus

3. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

4. Early systemic inflammation induces neurodevelopmental disorders: results from ARTEMIS, a French multicenter study of juvenile rheumatisms and systemic autoimmune and auto-inflammatory disorders and meta-analysis

5. Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Novel Central Neuroinflammation Biomarkers

6. Quantitative analysis of the natural history of prolidase deficiency: description of 17 families and systematic review of published cases.

7. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

10. Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child

12. Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score

14. A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis

15. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

17. Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients

18. Differential Expression of Interferon-Alpha Protein Provides Clues to Tissue Specificity Across Type I Interferonopathies

19. NLRP3-associated autoinflammatory diseases: Phenotypic and molecular characteristics of germline versus somatic mutations

20. Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts

21. IFN-β plasmatic levels are best predictors of muscle disease activity than IFN-α in a longitudinal cohort of patients with juvenile dermatomyositis

23. Functional diversity ofNLRP3gain-of-function mutants associated with CAPS autoinflammation

28. Osteonecrosis in patients with juvenile dermatomyositis: is it associated with anti-MDA5 autoantibody?

29. Factors associated with poor prognosis of hip arthritis in juvenile idiopathic arthritis: Data from the JIR cohort

30. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

31. Role of anti-TNF in Pediatric Inflammatory Choroidal Neovascularization: A Case Series.

32. Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Novel Central Neuroinflammation Biomarkers

33. Association of atypical skin manifestations at the onset of systemic juvenile idiopathic arthritis with difficult-to-treat disease: A retrospective multicenter study

34. Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)

35. Development of a score for early identification of children with Kawasaki disease requiring second-line treatment in multi-ethnic populations in Europe: A multicentre retrospective cohort study

36. Correction to “Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study”

38. Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohort

39. Musculoskeletal Disease in MDA5‐Related Type I Interferonopathy: A Mendelian Mimic of Jaccoudʼs Arthropathy

44. Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study

45. Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases

46. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

47. Effet d’un traitement par hydroxychloroquine prescrit comme traitement de fond de rhumatismes inflammatoires chroniques ou maladies auto-immunes systémiques sur les tests diagnostiques et l’évolution de l’infection à SARS CoV-2 : étude de 871 patients

Catalog

Books, media, physical & digital resources